Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules

The duration of cross-neutralising antibody responses (cross-NAb) following HPV immunisation is unknown. We compared cross-NAb responses in cohort of girls who were either unimmunised or had received immunisation with one, two or three doses of 4vHPV (Gardasil(®), Merck Inc., Kenilworth, NJ, USA) si...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccines (Basel)
Autori principali: Toh, Zheng Quan, Kosasih, Jennie, Russell, Fiona M., Reyburn, Rita, Fong, James, Tuivaga, Evelyn, Ratu, Felisita T., Nguyen, Cattram D., Matanitobua, Silivia, Do, Lien Anh Ha, Menheniott, Trevelyan, Frazer, Ian H., Garland, Suzanne M., Mulholland, Edward Kim, Licciardi, Paul V.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963583/
https://ncbi.nlm.nih.gov/pubmed/31795211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7040200
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi